Published in Life Sci on June 16, 2000
Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci (2009) 1.13
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding. J Nucl Med (2010) 1.10
Selective syntheses of no-carrier-added 2- and 3-[18F]fluorohalopyridines through the radiofluorination of halopyridinyl(4'-methoxyphenyl)iodonium tosylates. Chem Commun (Camb) (2012) 1.05
Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors. PET Clin (2009) 0.85
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers. Synapse (2009) 0.84
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography. Bioorg Med Chem (2009) 0.78
PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis. Curr Cardiol Rep (2015) 0.76
Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet (1998) 5.85
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70
Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31
Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol (1993) 3.12
Gender-linked brain injury in experimental stroke. Stroke (1998) 3.08
Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (1988) 3.01
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92
Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia (2000) 2.82
Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75
Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab (1992) 2.70
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci (1998) 2.40
Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience (2009) 2.38
Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol (2000) 2.29
Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology (2000) 2.08
Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology (2002) 2.07
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (1986) 2.00
Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84
Performance standards in positron emission tomography. J Nucl Med (1991) 1.78
Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science (1984) 1.75
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67
Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry (1990) 1.64
Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology (2001) 1.61
Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry (1999) 1.59
17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke (1999) 1.58
Imaging dopamine receptors in the human brain by positron tomography. Science (1983) 1.55
L-methionine uptake by human cerebral cortex: maturation from infancy to old age. J Nucl Med (1991) 1.55
Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med (1996) 1.51
PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry (1997) 1.50
The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48
Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain. Anesthesiology (1989) 1.47
Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 1.46
The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem (1990) 1.44
Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol (1990) 1.41
Toward a useful measure of flood-field uniformity: can the beauty in the eye of the beholder be quantified? Eur J Nucl Med (1992) 1.40
Reliability and validity of an algorithm for fuzzy tissue segmentation of MRI. J Comput Assist Tomogr (1998) 1.40
The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 1.38
Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci U S A (1996) 1.32
Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect (2000) 1.29
Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry (1996) 1.27
Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry (2008) 1.25
Patterns of ventricular emptying by Fourier analysis of gated blood-pool studies. J Nucl Med (1980) 1.24
Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21
Correction for patient and organ movement in SPECT: application to exercise thallium-201 cardiac imaging. J Nucl Med (1988) 1.20
In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry (1995) 1.20
Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20
Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology (1992) 1.14
Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands. Eur J Med Chem (2001) 1.12
Duration of occupancy of opiate receptors by naltrexone. J Nucl Med (1988) 1.12
Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain (1983) 1.08
Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08
Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab (1989) 1.07
Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain (2002) 1.06
Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. J Biol Chem (1989) 1.06
Factor analysis of regional cerebral glucose metabolic rates in healthy men. Eur J Nucl Med (1992) 1.05
Mania after brain injury: neuroradiological and metabolic findings. Ann Neurol (1990) 1.05
MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J Cereb Blood Flow Metab (1996) 1.05
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry (2007) 1.05
2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem (1998) 1.04
Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience (1991) 1.04
Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res (1990) 1.03
Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol (2001) 1.02
In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann N Y Acad Sci (1988) 1.02
In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain. Synapse (1998) 1.01
Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry (2008) 1.01
Planar and high-resolution SPECT bone imaging in the diagnosis of facet syndrome. J Nucl Med (1995) 1.00
Simplified assessment of fine aerosol distribution in human airways. J Nucl Med (1988) 1.00
[11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptors. Nucl Med Biol (1999) 0.99
Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke (1998) 0.98
Differential effects of age on motor performance in two mouse strains. Neurobiol Aging (1981) 0.98
Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98
Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil. J Cereb Blood Flow Metab (1993) 0.98
2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol (1998) 0.98
Assessment of pulmonary airway reactivity with high-resolution CT. Radiology (1991) 0.98
Neuroprotective effects of group III mGluR in traumatic neuronal injury. J Neurotrauma (1997) 0.98
Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol (1988) 0.98
Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci (1997) 0.97
Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab (1997) 0.97
Nicotine induced up-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences. Synapse (1998) 0.96
Measurement of absolute left ventricular volume from gated blood pool studies. Circulation (1982) 0.96